Great West Life Assurance CO Kymera Therapeutics, Inc. Transaction History
Great West Life Assurance CO
- $53.1 Billion
- Q2 2024
A detailed history of Great West Life Assurance CO transactions in Kymera Therapeutics, Inc. stock. As of the latest transaction made, Great West Life Assurance CO holds 10,491 shares of KYMR stock, worth $483,425. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10,491
Previous 3,931
166.88%
Holding current value
$483,425
Previous $158,000
98.1%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding KYMR
# of Institutions
160Shares Held
63.1MCall Options Held
22.6KPut Options Held
14.4K-
Price T Rowe Associates Inc Baltimore, MD6.39MShares$294 Million0.02% of portfolio
-
Baker Bros. Advisors LP New York, NY6MShares$276 Million2.38% of portfolio
-
Atlas Venture Life Science Advisors, LLC5.35MShares$247 Million21.28% of portfolio
-
Bvf Inc San Francisco, CA5.16MShares$238 Million4.71% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.82MShares$222 Million0.0% of portfolio
About Kymera Therapeutics, Inc.
- Ticker KYMR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 54,705,800
- Market Cap $2.52B
- Description
- Kymera Therapeutics, Inc., a biopharmaceutical company, focuses on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body's own natural protein degradation system. It engages in developing IRAK4 program, which is in Phase I clinical trial for the treatment of immunolo...